Denosumab May Increase BMD in Women With Primary Hyperparathyroidism – Endocrinology Advisor

Denosumab May Increase BMD in Women With Primary HyperparathyroidismEndocrinology AdvisorA significant increase in bone mineral density was more frequent in women with primary hyperparathyroidism than in women with primary osteoporosis. In older women with primary hyperparathyroidism (PHPT)-related osteoporosis, treatment with denosumab …

Source:: Osteoporosis Feed

      

Last modified: February 16, 2018